ID | 32937 |
フルテキストURL | |
著者 |
Ikeda, Masashi
Department of Psychiatry, Fujita Health University School of Medicine
Iwata, Nakao
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Suzuki, Tatsuyo
Department of Psychiatry, Fujita Health University School of Medicine
Kitajima, Tsuyoshi
Department of Psychiatry, Fujita Health University School of Medicine
Yamanouchi, Yoshio
Department of Psychiatry, Fujita Health University School of Medicine
Kinoshiya, Yoko
Department of Psychiatry, Fujita Health University School of Medicine
Sekine, Yoshimoto
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Iyo, Masaomi
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Harano, Mutsuo
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Komiyama, Tokutaro
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Yamada, Mitsuhiko
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Sora, Ichiro
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Ujike, Hiroshi
Department of Neuropsychiatry, Okayama University Graduate School of Medicine and Dentistry
Inada, Toshiya
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
Ozaki, Norio
Japanese Genetics Initiative for Drug Abuse (JGIDA), Okayama University Graduate School of Medicine and Dentistry
|
抄録 | Recent evidence suggests that the AKT1-GSK3b signalling cascade partially mediates dopaminedependent behaviours. In relation to the pathophysiology of schizophrenia or methamphetamine (Meth) use disorder, AKT1 is a good candidate gene for such conditions. For schizophrenia, positive associations of SNPs and AKT1 haplotypes were reported in US and Japanese samples. To evaluate the association between AKT1 and Meth-use disorder, we conducted a case-control study of Japanese samples (182 patients and 437 controls). A positive association between a SNP and haplotypes was found, and the ‘signal’ SNP was the same SNP found to be associated with US schizophrenia, but not with Japanese schizophrenia. Our results indicate that AKT1 may play a possible role in the development of Meth-use disorder. Further investigation of these associations, together with evidence from previous animal studies, may open the way to elucidation of the pathophysiology of this condition. |
キーワード | Dopamine-dependent behaviours
linkage disequilibrium
substance-related disorders
|
備考 | Published with permission from the copyright holder.>br />
This is published in International Journal of Neuropsychopharmacology , 2006 Feb, volume 9, Issue.1, pp 77-81.
Publisher URL: http://dx.doi.org/10.1017/S1461145705005481 Direct access to Thomson Web of Science record Copyright © 2006 Cambridge University Press All rights reserved. |
発行日 | 2008-09-04
|
出版物タイトル |
International Journal of Neuropsychopharmacology
|
巻 | 9巻
|
号 | 1号
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
査読 |
有り
|
DOI | |
Web of Science KeyUT | |
Submission Path | neuroscience/4
|